Crossmark

Shifting the paradigm in high-risk prostate cancer: how good is TNM alone?

Published Online: 2023-10-26

Published Print: 2024-12

Authors

Aoun, Fouad

Helou, Elie

Albisinni, Simone https://orcid.org/0000-0001-5529-3064
License Information

Text and Data Mining valid from 2023-10-26

Version of Record valid from 2023-10-26
More Information

Article History

Received: 9 October 2023

Revised: 12 October 2023

Accepted: 17 October 2023

First Online: 26 October 2023

Competing interests

: The authors declare no competing interests.

Free to read: This content has been made available to all.

Document is current